Intercept Pharmaceuticals Announces Two New Sub-Groups For FLINT Trial: Analysts Comment
March 24, 2015 at 21:01 PM EDT
Intercept Pharmaceuticals develops drug treatments for chronic liver diseases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.